Eli Lilly LLY Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Eli Lilly’s reported figures.
Based on trailing twelve months.
The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eli Lilly's return on assets?
- Eli Lilly (LLY) reported return on assets of 24.5% in Q1 2026.
- How has Eli Lilly's return on assets changed year-over-year?
- Eli Lilly's return on assets increased by 69.4% year-over-year, from 14.5% to 24.5%.
- What is the long-term trend for Eli Lilly's return on assets?
- Over 5 years (2020 to 2025), Eli Lilly's return on assets has grown at a 8.4% compound annual growth rate (CAGR), from 14.4% to 21.6%.
- What does return on assets mean?
- How much profit the company squeezes out of everything it owns.
- How do you interpret return on assets?
- Higher means more productive assets. Unlike ROE, it is unaffected by leverage, so a wide ROE-minus-ROA gap flags a heavily levered balance sheet.
- How does return on assets compare across companies?
- Best compared within an industry — asset intensity varies enormously across sectors. Not meaningful for banks, whose assets are largely financial.